Sbi Securities Co., Ltd. Cue Biopharma, Inc. Transaction History
Sbi Securities Co., Ltd.
- $3.25 Trillion
- Q4 2024
A detailed history of Sbi Securities Co., Ltd. transactions in Cue Biopharma, Inc. stock. As of the latest transaction made, Sbi Securities Co., Ltd. holds 1 shares of CUE stock, worth $1. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1Holding current value
$1% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CUE
# of Institutions
52Shares Held
14.1MCall Options Held
14.4KPut Options Held
2.6K-
Bleichroeder LP New York, NY5MShares$6.95 Million1.28% of portfolio
-
Slate Path Capital LP New York, NY2.4MShares$3.34 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.03MShares$2.82 Million0.0% of portfolio
-
Black Rock Inc. New York, NY757KShares$1.05 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA509KShares$707,2690.0% of portfolio
About Cue Biopharma, Inc.
- Ticker CUE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,381,700
- Market Cap $49.2M
- Description
- Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target an...